Most clinical trial organizations don’t intentionally create disconnected technology environments.

A CTMS is added to solve one problem. An eTMF is selected to address another. Additional tools are introduced for randomization, eConsent, reporting, or patient engagement. Over time, what began as thoughtful purchasing decisions can become a complex web of systems that don’t always communicate well with one another.

Many sponsors and CROs eventually reach the same conclusion: there has to be a better way.

The challenge isn’t recognizing the problem. The challenge is figuring out how to move toward unifying clinical trial systems without disrupting active studies, frustrating users, or creating unnecessary risk.

The good news is that successful consolidation rarely happens through a massive technology overhaul. Instead, the most successful organizations take a phased approach that focuses on people, processes, and priorities before technology.

Why Organizations Delay Consolidation

In This Article

Most organizations can see the advantages of a more unified technology environment, but several concerns tend to slow progress.

They’re worried about:

Disrupting ongoing studies
Retraining users
Data migration challenges
Existing vendor contracts
Internal resistance to change
Whether the effort will be worth it

These concerns are valid. Clinical trial technology touches nearly every function involved in trial execution, and changes can have downstream effects throughout the study lifecycle.

That’s why successful consolidation efforts focus on risk reduction rather than speed.

Step 1: Identify Your Biggest Sources of Friction

Before discussing platforms, identify where current systems are creating problems.

Common examples include:

Duplicate data entry
Manual reconciliation between systems
Multiple user logins
Inconsistent reporting
Data transfer delays
Limited visibility across studies

Not every disconnected system creates a meaningful business problem.

Start by identifying the issues consuming the most time and resources.

Step 2: Get Stakeholders Aligned Early

This is often harder than the technology itself.

Clinical operations, data management, quality, regulatory, and executive leadership may all have different priorities.

Instead of presenting consolidation as an IT initiative, frame it as an operational improvement initiative.

The conversation should focus on questions such as:

What processes are slowing us down?
Where do errors most commonly occur?
Which systems create the most administrative burden?
What does success look like?

When stakeholders align around business goals, platform decisions become easier.

Step 3: Don’t Migrate Everything at Once

One of the biggest misconceptions about consolidation is that every study must move immediately.

In reality, many organizations begin by placing new studies on the unified platform while allowing existing studies to continue on their current systems.

This reduces disruption while giving teams time to become comfortable with new workflows.

It also allows organizations to identify issues early before expanding adoption.

Step 4: Focus on User Adoption

Even the best platform will struggle if users don’t embrace it.

Organizations often spend significant time evaluating technology and very little time thinking about adoption.

Successful transitions typically include:

Hands-on training
Workflow-based learning
Clearly defined support resources
Internal champions
Continuous feedback loops

The goal is not simply to launch a system.

The goal is to make people successful using it.

Step 5: Measure the Results

Organizations should establish success metrics before implementation begins.

Examples might include:

Reduced duplicate data entry
Less manual reconciliation
Faster study startup activities
Improved reporting visibility
Reduced administrative burden
Simplified vendor management

Without measurable goals, it becomes difficult to determine whether consolidation delivered the expected value.

Building a Long-Term Technology Strategy

Clinical trial software consolidation doesn’t have to be an all-or-nothing decision.

The organizations that succeed are rarely the ones that move the fastest. They’re the ones that take a deliberate approach, build stakeholder support, prioritize the most impactful improvements, and introduce change in manageable phases.

By starting with operational challenges rather than technology selection, sponsors and CROs can create a more unified clinical trial environment without placing ongoing studies at unnecessary risk.

Schedule A Demo